67 related articles for article (PubMed ID: 21329755)
21. Bioavailability of two dermal formulations of S(+)ibuprofen in rabbit.
González-Peñas E; Echeverría HC; Mosquera J; Esteras A; Bruseghini L
Arzneimittelforschung; 2003; 53(11):786-92. PubMed ID: 14677375
[TBL] [Abstract][Full Text] [Related]
22. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration.
Dominkus M; Nicolakis M; Kotz R; Wilkinson FE; Kaiser RR; Chlud K
Arzneimittelforschung; 1996 Dec; 46(12):1138-43. PubMed ID: 9006788
[TBL] [Abstract][Full Text] [Related]
23. Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
Ghosh LK; Ghosh NC; Chatterjee M; Gupta BK
Drug Dev Ind Pharm; 1998 May; 24(5):473-7. PubMed ID: 9876610
[TBL] [Abstract][Full Text] [Related]
24. Topical administration of racemic ibuprofen.
Millership JS; Collier PS
Chirality; 1997; 9(3):313-6. PubMed ID: 9176998
[TBL] [Abstract][Full Text] [Related]
25. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.
Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P
Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792
[TBL] [Abstract][Full Text] [Related]
26. Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution.
Park YJ; Kwon R; Quan QZ; Oh DH; Kim JO; Hwang MR; Koo YB; Woo JS; Yong CS; Choi HG
Arch Pharm Res; 2009 May; 32(5):767-72. PubMed ID: 19471892
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of IL-1 beta and ibuprofen after endotoxic challenge in mice.
Mansilla-Roselló A; Ferrón-Orihuela JA; Ruiz-Cabello F; Garrote-Lara D; Fernández-Mondéjar E; Delgado-Carrasco ML
J Surg Res; 1997 Feb; 67(2):199-204. PubMed ID: 9073568
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro.
Andrews P; Zhao X; Allen J; Li F; Chang M
Cancer Chemother Pharmacol; 2008 Feb; 61(2):203-14. PubMed ID: 17447067
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory response in patients undergoing uterine artery embolization as compared to patients undergoing conventional hysterectomy.
Brøchner AC; Mygil B; Elle B; Toft P
Acta Radiol; 2009 Dec; 50(10):1193-7. PubMed ID: 19922320
[TBL] [Abstract][Full Text] [Related]
30. Phosphatidylcholine association increases the anti-inflammatory and analgesic activity of ibuprofen in acute and chronic rodent models of joint inflammation: relationship to alterations in bioavailability and cyclooxygenase-inhibitory potency.
Lichtenberger LM; Romero JJ; de Ruijter WM; Behbod F; Darling R; Ashraf AQ; Sanduja SK
J Pharmacol Exp Ther; 2001 Jul; 298(1):279-87. PubMed ID: 11408553
[TBL] [Abstract][Full Text] [Related]
31. Comparison of adjunctive use of rofecoxib versus ibuprofen in the management of postoperative pain after uterine artery embolization.
Hovsepian DM; Mandava A; Pilgram TK; Holder AP; Wong V; Chan P; Patel T
J Vasc Interv Radiol; 2006 Apr; 17(4):665-70. PubMed ID: 16614150
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-10 attenuates TNF-alpha-induced interleukin-6 production in endometriotic stromal cells.
Tagashira Y; Taniguchi F; Harada T; Ikeda A; Watanabe A; Terakawa N
Fertil Steril; 2009 May; 91(5 Suppl):2185-92. PubMed ID: 18684450
[TBL] [Abstract][Full Text] [Related]
33. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
[TBL] [Abstract][Full Text] [Related]
34. Perioperative pharmacokinetics of ibuprofen enantiomers after rectal administration.
Kyllönen M; Olkkola KT; Seppälä T; Ryhänen P
Paediatr Anaesth; 2005 Jul; 15(7):566-73. PubMed ID: 15960640
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of S-(+)-ibuprofen as drug candidate for intra-articular drug delivery system.
Bédouet L; Pascale F; Bonneau M; Laurent A
Drug Dev Ind Pharm; 2015 Jan; 41(1):85-94. PubMed ID: 24168233
[TBL] [Abstract][Full Text] [Related]
36. Ibuprofen in patients with sepsis.
Zimmerli W; Widmer AF
N Engl J Med; 1997 Sep; 337(10):710. PubMed ID: 9280820
[No Abstract] [Full Text] [Related]
37. Computed tomography angiogram for failed uterine artery embolization.
McLucas B; Yaghmai B; Beller M
Minim Invasive Ther Allied Technol; 2009; 18(2):87-92. PubMed ID: 19259849
[TBL] [Abstract][Full Text] [Related]
38. Advances in uterine artery embolization (UAE). Guest editorial.
McLucas B
Minim Invasive Ther Allied Technol; 2009; 18(2):67-8. PubMed ID: 19259850
[No Abstract] [Full Text] [Related]
39. Optimisation of cosolvent concentration for topical drug delivery - II: influence of propylene glycol on ibuprofen permeation.
Watkinson RM; Guy RH; Hadgraft J; Lane ME
Skin Pharmacol Physiol; 2009; 22(4):225-30. PubMed ID: 19648784
[TBL] [Abstract][Full Text] [Related]
40. The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations.
Pargal A; Kelkar MG; Nayak PJ
Biopharm Drug Dispos; 1996 Aug; 17(6):511-9. PubMed ID: 8866042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
